FAQs on Molecular Diagnostics in Dermatology

Operating the PsorX-LabDisk requires just a microtome and a FFPE sample (that was already prepared for your microscopic analysis). Begin by cutting three slices, each 10 μm thick, and place them into the sample input slots of the LabDisk. Ensure the LabDisk is securely closed, then scan your user ID and sample ID. Insert the LabDisk into the LabDisk-Analyzer, which will automatically initiate the analysis.

Due to the straightforward and user-friendly workflow, only a single training session is required. Our customer service team will guide you through all essential steps and proper procedures. If you have any questions, feel free to reach out to the team at any time.

The LabDisk-Analyzer will display the final result directly on its screen, such as “Psoriasis probable” or “Psoriasis improbable” for the PsorX-LabDisk. Furthermore, the results are securely saved in the Dermagnostix cloud, allowing you to easily copy and paste them into your report.

Not at all. All our products are CE-IVD(R) compliant and designed as plug-and-play solutions. Dermagnostix takes care of all regulatory and validation requirements, ensuring that neither you nor your team needs to address these concerns.

No, the PsorX-LabDisk is currently limited to differentiating between psoriasis and eczema in general. However, the upcoming point-of-care product, PsorXD, will be enhanced to identify eczema, and psoriasis using minimally invasive sampling.

Currently, the Dermagnostix system is utilized by dermatopathology laboratories due to the requirement for FFPE samples. To request a molecular analysis, please contact your pathology laboratory. A minimal-invasive point-of-care test designed for dermatologists is currently in development.

The modular LabDisk design allows for quick development cycles, which is why there are already several products in the Dermagnostix pipeline. These include LymphX-LabDisk, a gene expression-based diagnostic tool that enables accurate differentiation between mycosis fungoides (MF), psoriasis, and eczema. Similarly, PatternX-LabDisk brings a new dimension to dermatopathology by identifying molecular patterns that redefine traditional disease classifications, enabling personalized and effective patient treatments. PsorXD-DermDisk a point-of-care product for dermatologists differentiates between eczema and psoriasis.

We are always open to collaborations with universities, hospitals or clinicans for studies or to implement new assays on the LabDisk. Our current focus is on dermatology but our system is not limited on this area. Please contact us to discuss your idea via info@dermagnostix.com or via the contact form.

Molecular diagnostics provide precise differentiation between complex skin conditions like psoriasis and eczema, reducing uncertainty and delivering objective results for personalized patient care.

The LabDisk-Analyzer automates time-consuming processes such as sample preparation and signal amplification, reducing human error and increasing efficiency.

Yes, the PsorX-LabDisk test is specifically designed for dermatopathology laboratories and integrates seamlessly into existing workflows.

The PsorX-LabDisk supports FFPE samples, a standard in dermatopathology, ensuring the highest level of precision in results.

Molecular diagnostics offer clear, objective insights into skin conditions that are challenging to differentiate clinically, supporting faster and more accurate treatment decisions.

Yes, dermatologists can access molecular diagnostics by collaborating with partner laboratories equipped with Dermagnostix solutions.

By delivering faster and more accurate diagnoses, we reduce uncertainty for patients and support personalized treatment plans.

Our portfolio currently includes tests for differentiating psoriasis and eczema, with pipeline products addressing other complex skin diseases such as tinea or mycosis fungoides